Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Stanford University
Nohla Therapeutics, Inc.
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey